Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
2021; Elsevier BV; Volume: 3; Issue: 6 Linguagem: Inglês
10.1016/j.jhepr.2021.100384
ISSN2589-5559
AutoresHamish Innes, Peter Jepsen, Scott McDonald, John Dillon, Victoria Hamill, Alan C. Yeung, Jennifer Benselin, April Went, Andrew Fraser, Andrew Bathgate, M. Azim Ansari, Stephen T. Barclay, David Goldberg, Peter Hayes, Philip J. Johnson, Eleanor Barnes, William L. Irving, Sharon Hutchinson, Indra Neil Guha,
Tópico(s)Hepatocellular Carcinoma Treatment and Prognosis
ResumoHepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of 6 HCC prediction models for UK patients with cirrhosis and a HCV virological cure.
Referência(s)